COMMUNIQUÉS West-GlobeNewswire

Publication in blood® Highlights Potential for GM-CSF Neutralization as a Solution for CAR-T Induced Neurotoxicity
16/05/2019
Severe neurotoxicity (NT) is a negative prognostic factor for overall survival with chimeric antigen receptor T-cell (CAR-T) therapy Prolonged exposure of corticosteroids for severe NT may negatively in fl uence overall [...]
Antares Pharma to Present at the B. Riley FBR Institutional Investor Conference
16/05/2019
EWING, N.J., May 16, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Fred M. Powell, Executive Vice President and Chief Financial Officer, will present at the B. Riley FBR Institutional [...]
The Cooper Companies to Present at William Blair Growth Stock Conference
16/05/2019
PLEASANTON, Calif., May 16, 2019 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) will present at the William Blair Growth Stock Conference in Chicago, IL, on June 5, 2019. Brian G. Andrews, Senior Vice [...]
Kane Biotech Announces First Quarter 2019 Earnings Conference Call and Business Update
16/05/2019
Conference Call to be held Thursday, May 23 at 4:30pm ET WINNIPEG, Manitoba, May 16, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE), (the “Corporation” or “Kane Biotech”), a biotechnology company engaged in the [...]
Vascepa® to Be Featured in Multiple Scientific Sessions at the National Lipid Association Annual Meeting
16/05/2019
Vascepa’s REDUCE-IT Trial Impact on Clinical Practice an Important Highlight BEDMINSTER, N.J. and DUBLIN, Ireland, May 16, 2019 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused [...]
Teladoc Health to Participate in Upcoming Investor Conferences
16/05/2019
PURCHASE, NY, May 16, 2019 (GLOBE NEWSWIRE) -- Teladoc Health , Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Jason Gorevic, chief executive officer, will participate in the following [...]
Axovant Announces Dosing of First Patient in Clinical Program for AXO-AAV-GM1, a Novel Gene Therapy for GM1 Gangliosidosis
16/05/2019
- Milestone marks the first patient with GM1 gangliosidosis treated with gene therapy- -Initial data expected in second half of 2019- -AXO-AAV-GM1 is Axovant’s third investigational gene therapy program to enter the [...]
NGM Bio Reports Recent Highlights and First Quarter 2019 Financial Results
16/05/2019
-- Advanced NGM282 into Phase 2b ALPINE 2/3 clinical study in NASH-- --Received $177.8 million in aggregate net proceeds in April from Initial Public Offering and private placement with Merck-- SOUTH SAN FRANCISCO, [...]
MannKind Announces Afrezza® Distribution Agreement in Australia
16/05/2019
WESTLAKE VILLAGE, Calif., May 16, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) today announced that it has entered into an exclusive marketing and distribution agreement with the AMSL Diabetes division [...]
National Lipid Association Statement Paper Provides Clinicians with Updated Guidance for Enhanced Value of PCSK9 Use in Select Patient Populations
16/05/2019
MIAMI, May 16, 2019 (GLOBE NEWSWIRE) -- The NLA today released a statement paper providing updated guidance to clinicians with identifying patient groups in which use of PCSK9 monoclonal antibodies (mAbs) provides a [...]
AVRA Medical Robotics Announces Extension of Research Agreement with University of Central Florida
16/05/2019
ORLANDO, Fla., May 16, 2019 (GLOBE NEWSWIRE) -- AVRA Medical Robotics, Inc. (the “Company” or “AVRA”) (OTCQB: AVMR), an emerging company that is creating the next generation of autonomous surgical robotics through the [...]
EssilorLuxottica: EssilorLuxottica 2019 Annual General Meeting
16/05/2019
EssilorLuxottica 2019 Annual General Meeting Adoption of all Board’s resolutions at ordinary and extraordinary General Meeting Rejection of the two additional resolutions proposed by certain shareholders Dividend [...]
EssilorLuxottica : Assemblée générale EssilorLuxottica 2019
16/05/2019
Assemblée générale EssilorLuxottica 2019 Adoption de toutes les résolutions de l’Assemblée Générale ordinaire et extraordinaire proposées par le Conseil Rejet des deux résolutions complémentaires proposées par certains [...]
GN Store Nord A/S announces the Reference Share Price and initial Strike Price in respect of its EUR 330 million zero-coupon convertible bond offering consisting of Bond with Warrant Units
16/05/2019
NOT FOR DISTRIBUTION OR RELEASE IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ITALY, OR ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW. [...]
CROSSJECT éligible PEA-PME
16/05/2019
Communiqué de Presse Crossject éligible au PEA-PME Dijon, le 16 mai 2019 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui développe et commercialisera prochainement un portefeuille de médicaments [...]
Sanjeev Luther, President and CEO of Rafael Pharmaceuticals, to be Honored by American Cancer Society at Annual Starry Night Gala
16/05/2019
Newark, NJ, May 16, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, announced today that Sanjeev Luther, President [...]
Genocea Announces Research Collaboration with Iovance to Explore Development of Neoantigen-Targeted TIL (Tumor-Infiltrating Lymphocyte) Products
16/05/2019
CAMBRIDGE, Mass., May 16, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc . (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today announced a research collaboration with [...]
Kommuniké från årsstämman i LIDDS
16/05/2019
Den 16 maj 2019 hölls årsstämma i LIDDS AB (publ). Nedan följer sammanfattning av de beslut som fattades. Beslut fattades med erforderlig majoritet . Vid stämman var 433 852 (1,88%) av totalt 23 051 188 aktier [...]
DEINOVE is now ready to start Phase II clinical trial for its antibiotic compound DNV3837
16/05/2019
DEINOVE is now ready to start Phase II clinical trial for its antibiotic compound DNV3837 Having reached a sufficient number of clinical centers, Phase II clinical trial testing the antibiotic candidate DNV3837 in [...]

Pages